Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$411,605
in 5 filings

Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 48 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-18 BOESS CARSTEN Director Grant or award +22,862 52,862
2026-06-18 BOESS CARSTEN Director Grant or award · Stock Option (Right to Buy) +64,860 64,860
2025-06-18 BOESS CARSTEN Director Grant or award +30,000 30,000
2024-06-13 BOESS CARSTEN Director Grant or award · Stock Option (Right to Buy) +23,944 23,944
2023-06-22 BOESS CARSTEN Director Grant or award · Stock Option (Right to Buy) +25,850 25,850
2022-06-13 BOESS CARSTEN Director Grant or award · Stock Option (Right to Buy) +47,745 47,745
2021-06-14 BOESS CARSTEN Director Grant or award · Stock Option (Right to Buy) +12,236 12,236
2020-06-16 BOESS CARSTEN Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2019-01-28 BOESS CARSTEN Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2018-03-29 BOESS CARSTEN Director Grant or award · Stock Option (Right to Buy) +40,000 40,000

Page 1 of 1 · 10 trades